Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peri-infarct depolarizations are recurring, spreading waves of sustained neuronal and glial depolarization that occur in regions surrounding a focal cerebral infarct (the penumbra) or traumatized cortex. They are triggered by anoxic release of potassium and excitatory amino acids from infarcted tissue and propagate across the cortex at a rate of approximately 3 mm/min. These events induce metabolic stress, expression of immediate early genes and stress proteins, and can result in hypoxic injury and stepwise expansion of the infarct core if perfusion is inadequate[1][2][5]. Suppression of peri-infarct depolarizations using NMDA/non-NMDA receptor antagonists or sodium channel blockers has been shown to minimize infarct size and improve outcomes in preclinical models, making the process a therapeutic target for neuroprotection in stroke and related brain injuries[1][3].
Suppression of glutamate-mediated excitotoxic depolarizations; Prevention of electrical propagation of depolarizations; Reduction in expression of stress response proteins and infarct size[1][3]
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peri-infarct depolarization (PID).